Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Review and Preview
Review and Preview
Eukaryotic Transcription Inhibitors
Oral Cavity
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 9, 2026

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
Published on: December 31, 2017
Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is standard after acute coronary syndrome. This review compares the efficacy and safety of oral P2Y12 inhibitors: clopidogrel, prasugrel, and ticagrelor.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: